SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-057772
Filing Date
2023-11-02
Accepted
2023-11-02 08:50:35
Documents
16
Period of Report
2023-11-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gern-20231101.htm   iXBRL 8-K 61751
2 EX-5.1 gern-ex5_1.htm EX-5.1 21484
3 EX-10.1 gern-ex10_1.htm EX-10.1 359370
4 EX-99.1 gern-ex99_1.htm EX-99.1 171261
5 GRAPHIC img50521483_0.jpg GRAPHIC 56707
  Complete submission text file 0000950170-23-057772.txt   890436

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gern-20231101.xsd EX-101.SCH 2367
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gern-20231101_lab.xml EX-101.LAB 13360
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gern-20231101_pre.xml EX-101.PRE 10889
10 EXTRACTED XBRL INSTANCE DOCUMENT gern-20231101_htm.xml XML 4698
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 231370285
SIC: 2834 Pharmaceutical Preparations